Verona Pharma American Depositary Share research and development expenses for the twelve months ending December 31, 2024 were $0.045B, a 158.91% increase year-over-year.
Verona Pharma American Depositary Share annual research and development expenses for 2024 were $0.045B, a 158.91% increase from 2023.
Verona Pharma American Depositary Share annual research and development expenses for 2023 were $0.017B, a 65.07% decline from 2022.
Verona Pharma American Depositary Share annual research and development expenses for 2022 were $0.049B, a 37.94% decline from 2021.
Verona Pharma American Depositary Share Research and Development Expenses 2017-2024 | VRNA